Jacobs Levy Equity Management, Inc Praxis Precision Medicines, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$0.87 - $1.71 $543,006 - $1.07 Million	-624,145 Reduced 47.73%	683,379 $1.17 Million
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $1.09 Million - $1.54 Million	1,307,524 New	1,307,524 $1.5 Million
Q4 2022 Feb 14, 2023	SELL	$1.88 - $36.45 $28,254 - $547,807	-15,029 Reduced 5.63%	252,017 $599,000
Q3 2022 Nov 15, 2022	BUY	$2.5 - $37.95 $667,615 - $10.1 Million	267,046 New	267,046 $606,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.